The global super disintegrant market is anticipated to grow at considerable CAGR during the forecast year. Super disintegrants are chemical agents that dissolve or disintegrate very quickly. The drugs made using super disintegrants are tended to dissolve in water by wicking or any other mechanism. The benefit of super disintegrants drugs includes that they are more efficient treatment of the symptoms as the drug quickly reaches its target point. It is used for the treatment of several diseases including gastrointestinal, neurological, cancer, infectious, inflammatory diseases, and others.
One of the major factors for the growth of the market is the increasing adoption of orally disintegrating tablets (ODTs) for the treatment among patients. Furthermore, the prevalence of hematological diseases across the globe has increased the demand for super disintegrants for treatment. According to the report of Global Burden of Disease od 2019, the most common disease having some major health consequences is Anemia affecting 40% of children and 30% of reproductive-age women. Resulting in more demands for super disintegrants for better treatment, thus, growing the global super disintegrant market.
Impact of COVID-19 on Global Super Disintegrant Market
COVID-19 has impacted the global economy due to a slowdown in the manufacturing of various industries. The market for super disintegrant is not affected during COVID-19 as there are several diseases that can be treated using super disintegrants. Due to decreased physical activities and more eating during the lockdown, gastrointestinal diseases increased resulting in increased demand for super disintegrants.
Segmental Outlook
The global super disintegrant market is segmented based on type and application. Based on type, the market is sub-segmented into natural super disintegrants and synthetic super disintegrants. Based on application, the market is sub-segmented into gastrointestinal diseases, neurological diseases, cardiovascular diseases, oncology, infectious diseases, hematological diseases, and inflammatory diseases. Among these, the synthetic super disintegrants segment is expected to hold a prominent share in the global super disintegrant market due to several benefits including bioavailability, stability, the increased mechanical strength of drugs, and many others.
Global Super Disintegrant Market by Application, 2021(%)
The Cardiovascular Diseases Segment is Anticipated to Hold a Major Share in the Global Super Disintegrant market.
The use of super disintegrant for the treatment of cardiovascular diseases segment is contributing to the growth of cardiovascular disease segment in the global super disintegrant market. Cardiovascular diseases include rheumatic heart disease, peripheral arterial disease, cerebrovascular disease, coronary heart disease, congenital heart disease, and others. According to a report published by World Health Organization (WHO) in June 2021, cardiovascular diseases were considered one of the major causes of death globally. Around 17.9 million people died due to cardiovascular diseases in 2019, representing 32% of all global deaths.
Regional Outlooks
The global super disintegrant market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The North American region is expected to hold the major share in the global super disintegrant market due to the presence of several key players and increased adoption of orally disintegrating tablets (ODTs) in the region.
Global Super Disintegrant Market Growth by Region, 2022-2028
The Asia Pacific Region is Expected to Hold a Prominent Share in the Global Super Disintegrant Market
The Asia Pacific regional super disintegrant market is anticipated to grow at a significant CAGR during the forecast year due to the prevalence of gastrointestinal diseases in the developing countries of the region including India. Gastrointestinal diseases are increasing in India due to several reasons including bad lifestyle, unclean water or sanitation, decreased exercise or health activities, and irregular or unhealthy food habits resulting in increased demand for super disintegrants for treatment, thus, propelling the growth of the Asia Pacific regional super disintegrant market.
Market Players Outlook
The major companies serving the global Super Disintegrant market include Ashland Global Holdings Inc., BASF, DFE Pharma, JRS PHARMA GmbH + Co. KG, Roquette, and many others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, fundings, and new product launches. For instance, The US Food and Drug Administration (FDA) authorised a New Drug Application (NDA) for DARTISLA ODT glycopyrrolate orally disintegrating tablets in December 2021. Edenbridge Pharmaceuticals LLC created the medication, which can be used to treat peptic ulcers in adults.
The Report Covers
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Super Disintegrant Market
• Recovery Scenario of Global Super Disintegrant Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Ashland Global Holdings Inc.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. BASF
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. DFE Pharma
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. JRS PHARMA GmbH & Co. KG
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Roquette
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Super Disintegrant Market by Type
4.1.1. Natural Super Disintegrant
4.1.2. Synthetic Super Disintegrant
4.2. Global Super Disintegrant Market by Application
4.2.1. Gastrointestinal Diseases
4.2.2. Neurological Diseases
4.2.3. Cardiovascular Diseases
4.2.4. Oncology
4.2.5. Infectious Diseases
4.2.6. Hematological Diseases
4.2.7. Inflammatory Diseases
5. Regional Analysis
5.1. North America
5.1.1. The US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Asahi Kasei Corp.
6.2. Avantor, Inc.
6.3. Coral Pharma Chem
6.4. DKSH India
6.5. Dow Chemical Co.
6.6. Edenbridge Pharmaceuticals LLC
6.7. Evonik Industries AG
6.8. FMC Corp.
6.9. J.M, Huber Corp.
6.10. Merck Group
6.11. Nippon Soda Co., Ltd.
6.12. Rochem International Inc.
1. GLOBAL SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL NATURAL SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL SYNTHETIC SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
5. GLOBAL SUPER DISINTEGRANT FOR GASTROINTESTINAL DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL SUPER DISINTEGRANT FOR NEUROLOGICAL DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL SUPER DISINTEGRANT FOR CARDIOVASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL SUPER DISINTEGRANT FOR ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL SUPER DISINTEGRANT FOR INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL SUPER DISINTEGRANT FOR HEMATOLOGICAL DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL SUPER DISINTEGRANT FOR INFLAMMATORY DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
13. NORTH AMERICAN SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
14. NORTH AMERICAN SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
15. NORTH AMERICAN SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
16. EUROPEAN SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. EUROPEAN SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
18. EUROPEAN SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
21. ASIA-PACIFIC SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
22. REST OF THE WORLD SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23. REST OF THE WORLD SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
24. REST OF THE WORLD SUPER DISINTEGRANT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL SUPER DISINTEGRANT MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL SUPER DISINTEGRANT MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL SUPER DISINTEGRANT MARKET, 2021-2028 (%)
4. GLOBAL SUPER DISINTEGRANT MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL NATURAL SUPER DISINTEGRANT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL SYNTHETIC SUPER DISINTEGRANT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL SUPER DISINTEGRANT MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
8. GLOBAL SUPER DISINTEGRANT FOR GASTROINTESTINAL DISEASES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL SUPER DISINTEGRANT FOR NEUROLOGICAL DISEASES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL SUPER DISINTEGRANT FOR CARDIOVASCULAR DISEASES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL SUPER DISINTEGRANT FOR ONCOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL SUPER DISINTEGRANT FOR INFECTIOUS DISEASES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL SUPER DISINTEGRANT FOR HEMATALOGICAL DISEASES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL SUPER DISINTEGRANT FOR INFLAMMATORY DISEASES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL SUPER DISINTEGRANT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. US SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
17. CANADA SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
18. UK SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
19. FRANCE SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
20. GERMANY SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
21. ITALY SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
22. SPAIN SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
23. REST OF EUROPE SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
24. INDIA SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
25. CHINA SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
26. JAPAN SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
27. SOUTH KOREA SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF ASIA-PACIFIC SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF THE WORLD SUPER DISINTEGRANT MARKET SIZE, 2021-2028 ($ MILLION)